Global Intravenous Immunoglobulin(IVIg) Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 154

Published Date: 11 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Intravenous Immunoglobulin(IVIg) Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Intravenous Immunoglobulin(IVIg) Therapy industry chain, the market status of Immunodeficiency (1g/20ml, 1.25g/25ml), Autoimmune Disease (1g/20ml, 1.25g/25ml), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravenous Immunoglobulin(IVIg) Therapy.

Regionally, the report analyzes the Intravenous Immunoglobulin(IVIg) Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravenous Immunoglobulin(IVIg) Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Intravenous Immunoglobulin(IVIg) Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravenous Immunoglobulin(IVIg) Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 1g/20ml, 1.25g/25ml).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravenous Immunoglobulin(IVIg) Therapy market.

Regional Analysis: The report involves examining the Intravenous Immunoglobulin(IVIg) Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravenous Immunoglobulin(IVIg) Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Intravenous Immunoglobulin(IVIg) Therapy:
Company Analysis: Report covers individual Intravenous Immunoglobulin(IVIg) Therapy manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravenous Immunoglobulin(IVIg) Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immunodeficiency, Autoimmune Disease).

Technology Analysis: Report covers specific technologies relevant to Intravenous Immunoglobulin(IVIg) Therapy. It assesses the current state, advancements, and potential future developments in Intravenous Immunoglobulin(IVIg) Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intravenous Immunoglobulin(IVIg) Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Intravenous Immunoglobulin(IVIg) Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
1g/20ml
1.25g/25ml
2.5g/50ml
5g/100ml
10g/200ml
Others

Market segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Others

Major players covered
TEIJIN LIMITED
Grifols
Biotest
Kamada
Takeda
Octapharma
Kedrion
LFB Group
Baxter
Nanyue Biopharming
Boya-Bio
CSL Plasma
CNBG
Beijing Tiantan Biological Products
Hualan Bio
Guangdong Shuagnlin Bio-pharmacy
Weiguang Biological
Sinopharm
Shanghai RAAS
Taibang Biologic Group

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Immunoglobulin(IVIg) Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravenous Immunoglobulin(IVIg) Therapy, with price, sales, revenue and global market share of Intravenous Immunoglobulin(IVIg) Therapy from 2019 to 2024.
Chapter 3, the Intravenous Immunoglobulin(IVIg) Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Immunoglobulin(IVIg) Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Intravenous Immunoglobulin(IVIg) Therapy market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravenous Immunoglobulin(IVIg) Therapy.
Chapter 14 and 15, to describe Intravenous Immunoglobulin(IVIg) Therapy sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Intravenous Immunoglobulin(IVIg) Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 1g/20ml
        1.3.3 1.25g/25ml
        1.3.4 2.5g/50ml
        1.3.5 5g/100ml
        1.3.6 10g/200ml
        1.3.7 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Immunodeficiency
        1.4.3 Autoimmune Disease
        1.4.4 Acute Infection
        1.4.5 Others
    1.5 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size & Forecast
        1.5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (2019-2030)
        1.5.3 Global Intravenous Immunoglobulin(IVIg) Therapy Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 TEIJIN LIMITED
        2.1.1 TEIJIN LIMITED Details
        2.1.2 TEIJIN LIMITED Major Business
        2.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.1.4 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 TEIJIN LIMITED Recent Developments/Updates
    2.2 Grifols
        2.2.1 Grifols Details
        2.2.2 Grifols Major Business
        2.2.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.2.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Grifols Recent Developments/Updates
    2.3 Biotest
        2.3.1 Biotest Details
        2.3.2 Biotest Major Business
        2.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.3.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Biotest Recent Developments/Updates
    2.4 Kamada
        2.4.1 Kamada Details
        2.4.2 Kamada Major Business
        2.4.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.4.4 Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Kamada Recent Developments/Updates
    2.5 Takeda
        2.5.1 Takeda Details
        2.5.2 Takeda Major Business
        2.5.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.5.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Takeda Recent Developments/Updates
    2.6 Octapharma
        2.6.1 Octapharma Details
        2.6.2 Octapharma Major Business
        2.6.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.6.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Octapharma Recent Developments/Updates
    2.7 Kedrion
        2.7.1 Kedrion Details
        2.7.2 Kedrion Major Business
        2.7.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.7.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Kedrion Recent Developments/Updates
    2.8 LFB Group
        2.8.1 LFB Group Details
        2.8.2 LFB Group Major Business
        2.8.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.8.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 LFB Group Recent Developments/Updates
    2.9 Baxter
        2.9.1 Baxter Details
        2.9.2 Baxter Major Business
        2.9.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.9.4 Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Baxter Recent Developments/Updates
    2.10 Nanyue Biopharming
        2.10.1 Nanyue Biopharming Details
        2.10.2 Nanyue Biopharming Major Business
        2.10.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.10.4 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Nanyue Biopharming Recent Developments/Updates
    2.11 Boya-Bio
        2.11.1 Boya-Bio Details
        2.11.2 Boya-Bio Major Business
        2.11.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.11.4 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Boya-Bio Recent Developments/Updates
    2.12 CSL Plasma
        2.12.1 CSL Plasma Details
        2.12.2 CSL Plasma Major Business
        2.12.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.12.4 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 CSL Plasma Recent Developments/Updates
    2.13 CNBG
        2.13.1 CNBG Details
        2.13.2 CNBG Major Business
        2.13.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.13.4 CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 CNBG Recent Developments/Updates
    2.14 Beijing Tiantan Biological Products
        2.14.1 Beijing Tiantan Biological Products Details
        2.14.2 Beijing Tiantan Biological Products Major Business
        2.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.14.4 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Beijing Tiantan Biological Products Recent Developments/Updates
    2.15 Hualan Bio
        2.15.1 Hualan Bio Details
        2.15.2 Hualan Bio Major Business
        2.15.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.15.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Hualan Bio Recent Developments/Updates
    2.16 Guangdong Shuagnlin Bio-pharmacy
        2.16.1 Guangdong Shuagnlin Bio-pharmacy Details
        2.16.2 Guangdong Shuagnlin Bio-pharmacy Major Business
        2.16.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.16.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
    2.17 Weiguang Biological
        2.17.1 Weiguang Biological Details
        2.17.2 Weiguang Biological Major Business
        2.17.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.17.4 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Weiguang Biological Recent Developments/Updates
    2.18 Sinopharm
        2.18.1 Sinopharm Details
        2.18.2 Sinopharm Major Business
        2.18.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.18.4 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.18.5 Sinopharm Recent Developments/Updates
    2.19 Shanghai RAAS
        2.19.1 Shanghai RAAS Details
        2.19.2 Shanghai RAAS Major Business
        2.19.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.19.4 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.19.5 Shanghai RAAS Recent Developments/Updates
    2.20 Taibang Biologic Group
        2.20.1 Taibang Biologic Group Details
        2.20.2 Taibang Biologic Group Major Business
        2.20.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        2.20.4 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.20.5 Taibang Biologic Group Recent Developments/Updates

3 Competitive Environment: Intravenous Immunoglobulin(IVIg) Therapy by Manufacturer
    3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Manufacturer (2019-2024)
    3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Intravenous Immunoglobulin(IVIg) Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Intravenous Immunoglobulin(IVIg) Therapy Manufacturer Market Share in 2023
        3.4.2 Top 6 Intravenous Immunoglobulin(IVIg) Therapy Manufacturer Market Share in 2023
    3.5 Intravenous Immunoglobulin(IVIg) Therapy Market: Overall Company Footprint Analysis
        3.5.1 Intravenous Immunoglobulin(IVIg) Therapy Market: Region Footprint
        3.5.2 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
        3.5.3 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Region
        4.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Region (2019-2030)
        4.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Region (2019-2030)
        4.1.3 Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2019-2030)
    4.2 North America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019-2030)
    4.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019-2030)
    4.4 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019-2030)
    4.5 South America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019-2030)
    4.6 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2030)
    5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Type (2019-2030)
    5.3 Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2030)
    6.2 Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Application (2019-2030)
    6.3 Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2019-2030)

7 North America
    7.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2030)
    7.2 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2030)
    7.3 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
        7.3.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Country (2019-2030)
        7.3.2 North America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2030)
    8.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2030)
    8.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
        8.3.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Country (2019-2030)
        8.3.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size by Region
        9.3.1 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2030)
    10.2 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2030)
    10.3 South America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
        10.3.1 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Country (2019-2030)
        10.3.2 South America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
        11.3.1 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
    12.2 Intravenous Immunoglobulin(IVIg) Therapy Market Restraints
    12.3 Intravenous Immunoglobulin(IVIg) Therapy Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Intravenous Immunoglobulin(IVIg) Therapy and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Intravenous Immunoglobulin(IVIg) Therapy
    13.3 Intravenous Immunoglobulin(IVIg) Therapy Production Process
    13.4 Intravenous Immunoglobulin(IVIg) Therapy Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
    14.3 Intravenous Immunoglobulin(IVIg) Therapy Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. TEIJIN LIMITED Basic Information, Manufacturing Base and Competitors
    Table 4. TEIJIN LIMITED Major Business
    Table 5. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 6. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. TEIJIN LIMITED Recent Developments/Updates
    Table 8. Grifols Basic Information, Manufacturing Base and Competitors
    Table 9. Grifols Major Business
    Table 10. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 11. Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Grifols Recent Developments/Updates
    Table 13. Biotest Basic Information, Manufacturing Base and Competitors
    Table 14. Biotest Major Business
    Table 15. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 16. Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Biotest Recent Developments/Updates
    Table 18. Kamada Basic Information, Manufacturing Base and Competitors
    Table 19. Kamada Major Business
    Table 20. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 21. Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Kamada Recent Developments/Updates
    Table 23. Takeda Basic Information, Manufacturing Base and Competitors
    Table 24. Takeda Major Business
    Table 25. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 26. Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Takeda Recent Developments/Updates
    Table 28. Octapharma Basic Information, Manufacturing Base and Competitors
    Table 29. Octapharma Major Business
    Table 30. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 31. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Octapharma Recent Developments/Updates
    Table 33. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 34. Kedrion Major Business
    Table 35. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 36. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Kedrion Recent Developments/Updates
    Table 38. LFB Group Basic Information, Manufacturing Base and Competitors
    Table 39. LFB Group Major Business
    Table 40. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 41. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. LFB Group Recent Developments/Updates
    Table 43. Baxter Basic Information, Manufacturing Base and Competitors
    Table 44. Baxter Major Business
    Table 45. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 46. Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Baxter Recent Developments/Updates
    Table 48. Nanyue Biopharming Basic Information, Manufacturing Base and Competitors
    Table 49. Nanyue Biopharming Major Business
    Table 50. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 51. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Nanyue Biopharming Recent Developments/Updates
    Table 53. Boya-Bio Basic Information, Manufacturing Base and Competitors
    Table 54. Boya-Bio Major Business
    Table 55. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 56. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Boya-Bio Recent Developments/Updates
    Table 58. CSL Plasma Basic Information, Manufacturing Base and Competitors
    Table 59. CSL Plasma Major Business
    Table 60. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 61. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. CSL Plasma Recent Developments/Updates
    Table 63. CNBG Basic Information, Manufacturing Base and Competitors
    Table 64. CNBG Major Business
    Table 65. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 66. CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 67. CNBG Recent Developments/Updates
    Table 68. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
    Table 69. Beijing Tiantan Biological Products Major Business
    Table 70. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 71. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 72. Beijing Tiantan Biological Products Recent Developments/Updates
    Table 73. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 74. Hualan Bio Major Business
    Table 75. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 76. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Hualan Bio Recent Developments/Updates
    Table 78. Guangdong Shuagnlin Bio-pharmacy Basic Information, Manufacturing Base and Competitors
    Table 79. Guangdong Shuagnlin Bio-pharmacy Major Business
    Table 80. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 81. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 82. Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
    Table 83. Weiguang Biological Basic Information, Manufacturing Base and Competitors
    Table 84. Weiguang Biological Major Business
    Table 85. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 86. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 87. Weiguang Biological Recent Developments/Updates
    Table 88. Sinopharm Basic Information, Manufacturing Base and Competitors
    Table 89. Sinopharm Major Business
    Table 90. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 91. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 92. Sinopharm Recent Developments/Updates
    Table 93. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
    Table 94. Shanghai RAAS Major Business
    Table 95. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 96. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 97. Shanghai RAAS Recent Developments/Updates
    Table 98. Taibang Biologic Group Basic Information, Manufacturing Base and Competitors
    Table 99. Taibang Biologic Group Major Business
    Table 100. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 101. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 102. Taibang Biologic Group Recent Developments/Updates
    Table 103. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 104. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 105. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 106. Market Position of Manufacturers in Intravenous Immunoglobulin(IVIg) Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 107. Head Office and Intravenous Immunoglobulin(IVIg) Therapy Production Site of Key Manufacturer
    Table 108. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
    Table 109. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
    Table 110. Intravenous Immunoglobulin(IVIg) Therapy New Market Entrants and Barriers to Market Entry
    Table 111. Intravenous Immunoglobulin(IVIg) Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 112. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Region (2019-2024) & (K Units)
    Table 113. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Region (2025-2030) & (K Units)
    Table 114. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 115. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 116. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2019-2024) & (US$/Unit)
    Table 117. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2025-2030) & (US$/Unit)
    Table 118. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2024) & (K Units)
    Table 119. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2025-2030) & (K Units)
    Table 120. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 121. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 122. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2019-2024) & (US$/Unit)
    Table 123. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2025-2030) & (US$/Unit)
    Table 124. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2024) & (K Units)
    Table 125. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2025-2030) & (K Units)
    Table 126. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 127. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 128. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2019-2024) & (US$/Unit)
    Table 129. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2025-2030) & (US$/Unit)
    Table 130. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2024) & (K Units)
    Table 131. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2025-2030) & (K Units)
    Table 132. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2024) & (K Units)
    Table 133. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2025-2030) & (K Units)
    Table 134. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Country (2019-2024) & (K Units)
    Table 135. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Country (2025-2030) & (K Units)
    Table 136. North America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 137. North America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 138. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2024) & (K Units)
    Table 139. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2025-2030) & (K Units)
    Table 140. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2024) & (K Units)
    Table 141. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2025-2030) & (K Units)
    Table 142. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Country (2019-2024) & (K Units)
    Table 143. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Country (2025-2030) & (K Units)
    Table 144. Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 145. Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 146. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2024) & (K Units)
    Table 147. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2025-2030) & (K Units)
    Table 148. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2024) & (K Units)
    Table 149. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2025-2030) & (K Units)
    Table 150. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Region (2019-2024) & (K Units)
    Table 151. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Region (2025-2030) & (K Units)
    Table 152. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 153. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 154. South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2024) & (K Units)
    Table 155. South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2025-2030) & (K Units)
    Table 156. South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2024) & (K Units)
    Table 157. South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2025-2030) & (K Units)
    Table 158. South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Country (2019-2024) & (K Units)
    Table 159. South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Country (2025-2030) & (K Units)
    Table 160. South America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 161. South America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 162. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2019-2024) & (K Units)
    Table 163. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Type (2025-2030) & (K Units)
    Table 164. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2019-2024) & (K Units)
    Table 165. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Application (2025-2030) & (K Units)
    Table 166. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Region (2019-2024) & (K Units)
    Table 167. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity by Region (2025-2030) & (K Units)
    Table 168. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 169. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 170. Intravenous Immunoglobulin(IVIg) Therapy Raw Material
    Table 171. Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy Raw Materials
    Table 172. Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
    Table 173. Intravenous Immunoglobulin(IVIg) Therapy Typical Customers
List of Figures
    Figure 1. Intravenous Immunoglobulin(IVIg) Therapy Picture
    Figure 2. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Type in 2023
    Figure 4. 1g/20ml Examples
    Figure 5. 1.25g/25ml Examples
    Figure 6. 2.5g/50ml Examples
    Figure 7. 5g/100ml Examples
    Figure 8. 10g/200ml Examples
    Figure 9. Others Examples
    Figure 10. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 11. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Application in 2023
    Figure 12. Immunodeficiency Examples
    Figure 13. Autoimmune Disease Examples
    Figure 14. Acute Infection Examples
    Figure 15. Others Examples
    Figure 16. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 17. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 18. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity (2019-2030) & (K Units)
    Figure 19. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price (2019-2030) & (US$/Unit)
    Figure 20. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Manufacturer in 2023
    Figure 21. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Manufacturer in 2023
    Figure 22. Producer Shipments of Intravenous Immunoglobulin(IVIg) Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 23. Top 3 Intravenous Immunoglobulin(IVIg) Therapy Manufacturer (Consumption Value) Market Share in 2023
    Figure 24. Top 6 Intravenous Immunoglobulin(IVIg) Therapy Manufacturer (Consumption Value) Market Share in 2023
    Figure 25. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Region (2019-2030)
    Figure 26. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 27. North America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 28. Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 29. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 30. South America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 31. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 32. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Type (2019-2030)
    Figure 33. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 34. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2019-2030) & (US$/Unit)
    Figure 35. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Application (2019-2030)
    Figure 36. Global Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 37. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2019-2030) & (US$/Unit)
    Figure 38. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Type (2019-2030)
    Figure 39. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Application (2019-2030)
    Figure 40. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Country (2019-2030)
    Figure 41. North America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 42. United States Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 43. Canada Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. Mexico Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Type (2019-2030)
    Figure 46. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Application (2019-2030)
    Figure 47. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Country (2019-2030)
    Figure 48. Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 49. Germany Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. France Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. United Kingdom Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 52. Russia Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Italy Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Type (2019-2030)
    Figure 55. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Application (2019-2030)
    Figure 56. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Region (2019-2030)
    Figure 57. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 58. China Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. India Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 62. Southeast Asia Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Australia Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Type (2019-2030)
    Figure 65. South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Application (2019-2030)
    Figure 66. South America Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Country (2019-2030)
    Figure 67. South America Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 68. Brazil Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Argentina Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Type (2019-2030)
    Figure 71. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Application (2019-2030)
    Figure 72. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Quantity Market Share by Region (2019-2030)
    Figure 73. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 74. Turkey Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Egypt Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 76. Saudi Arabia Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 77. South Africa Intravenous Immunoglobulin(IVIg) Therapy Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 78. Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
    Figure 79. Intravenous Immunoglobulin(IVIg) Therapy Market Restraints
    Figure 80. Intravenous Immunoglobulin(IVIg) Therapy Market Trends
    Figure 81. Porters Five Forces Analysis
    Figure 82. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy in 2023
    Figure 83. Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
    Figure 84. Intravenous Immunoglobulin(IVIg) Therapy Industrial Chain
    Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 86. Direct Channel Pros & Cons
    Figure 87. Indirect Channel Pros & Cons
    Figure 88. Methodology
    Figure 89. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

TEIJIN LIMITED
Grifols
Biotest
Kamada
Takeda
Octapharma
Kedrion
LFB Group
Baxter
Nanyue Biopharming
Boya-Bio
CSL Plasma
CNBG
Beijing Tiantan Biological Products
Hualan Bio
Guangdong Shuagnlin Bio-pharmacy
Weiguang Biological
Sinopharm
Shanghai RAAS
Taibang Biologic Group

Related Reports

Global Intravenous Immunoglobulin(IVIg) Therapy Supply, Demand and Key Producers, 2023-2029

Global Intravenous Immunoglobulin(IVIg) Therapy Supply, Demand and Key Producers, 2023-2029

date 17 Feb 2023

date Pharma & Healthcare

The global Intravenous Immunoglobulin(IVIg) Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Intravenous Immunoglobulin(IVIg) Therapy Supply, Demand and Key Producers, 2024-2030

Global Intravenous Immunoglobulin(IVIg) Therapy Supply, Demand and Key Producers, 2024-2030

date 01 Mar 2024

date Pharma & Healthcare

The global Intravenous Immunoglobulin(IVIg) Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Intravenous Immunoglobulin(IVIg) Therapy

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>